Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,322 | 6,358 | 7,840 | 2,701 | 4,844 |
| Receivables | 11,456 | 16,548 | 18,176 | 16,311 | 16,673 |
| TOTAL | $24,206 | $25,757 | $29,658 | $22,471 | $24,984 |
| Non-Current Assets | |||||
| PPE Net | 20,251 | 20,423 | 21,433 | 23,740 | 26,628 |
| Investments And Advances | 305 | 261 | 1,188 | 978 | 1,156 |
| Other Non-Current Assets | 641 | 682 | 712 | 783 | 670 |
| TOTAL | $21,197 | $21,366 | $23,333 | $25,501 | $28,454 |
| Total Assets | $45,403 | $47,123 | $52,990 | $47,972 | $53,438 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 390 | 370 | 381 | 401 | 6,590 |
| Accounts payable and accrued liabilities | 8,167 | 11,055 | 11,345 | N/A | N/A |
| TOTAL | $9,842 | $11,518 | $11,960 | $10,052 | $14,232 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 308 | 404 | 481 | 605 | 2,257 |
| TOTAL | $2,327 | $2,215 | $2,437 | $1,434 | $3,308 |
| Total Liabilities | $12,169 | $13,732 | $14,397 | $11,486 | $17,540 |
| Shareholders' Equity | |||||
| Retained earnings | -11,512 | N/A | -8,846 | N/A | -6,493 |
| Other shareholders' equity | -523 | 33,390 | -505 | 36,486 | -5,873 |
| TOTAL | $33,234 | $33,390 | $38,593 | $36,486 | $35,898 |
| Total Liabilities And Equity | $45,403 | $47,123 | $52,990 | $47,972 | $53,438 |